Business
Investor buzz around cannabis stocks with new treatments – Sydney Morning Herald
Cannabis startups get down to business as treatments normalised and some small stocks are winning big name backers.
Last week ASX-listed Zelira Therapeutics, formerly Zelda Therapeutics, scored a new substantial shareholder when billionaire investor Alex Waislitz’s Thorney Investment Group upped its stake from 2 per cent to 5.2 per cent.
Earlier this month Zelira confirmed its cannabinoid insomnia medicine Zenivol had been made available in Australia under the nation’s special access scheme for cannabis products.
Thorney bumped its stake after a private placement of 37 million shares at 5.4c each.
“The str…
-
Noosa News21 hours agoBondi Beach terror attack: Police investigate threat against Westfield North Lakes in Queensland
-
Noosa News21 hours agoBrand update as firm marks 25 years – Proctor
-
Business24 hours agoWhy Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today
-
Noosa News21 hours agoNon-compliance, human error led to $2m Noosa Council fraud